Stocksigma LogoStocksigma Logo

Sudarshan Pharma Industries Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)

■ Revenue: 21,697 (+28.5% YoY | +24.4% QoQ) ■ EBITDA: 2,058 (+123.6% YoY | +29.4% QoQ) ■ EBITDA Margin (%): 9.5 (+404 bps YoY | +37 bps QoQ) ■ PAT: 809

Sudarshan Pharma Industries Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)

Sudarshan Pharma Industries Ltd · Financial Result · 30 Oct 2026, 3:56 am

Sudarshan Pharma Industries Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) ■ Revenue: 21,697 (+28.5% YoY | +24.4% QoQ) ■ EBITDA: 2,058 (+123.6% YoY | +29.4% QoQ) ■ EBITDA Margin (%): 9.5 (+404 bps YoY | +37 bps QoQ) ■ PAT: 809 (+93.3% YoY | +38.1% QoQ) ■ EPS (INR): 0.31 (+93.8% YoY | +34.8% QoQ)

Original exchange filing (PDF)

More announcements from Sudarshan Pharma Industries Ltd

All Sudarshan Pharma Industries Ltd announcements